Patients with chronic hepatitis C have a new option for treating the liver-damaging virus, with the approval of a combination treatment developed by AbbVie Inc.
The US Food and Drug Administration (FDA) on Friday approved the sale of a packaged treatment called Viekira Pak made by AbbVie of North Chicago, Illinois. It includes a combination pill, which contains the antiviral drugs ombitasvir, paritaprevir and ritonavir, along with a tablet of dasabuvir.
All the ingredients are new except for ritonavir, which works to increase blood levels of paritaprevir.
It is among several new pill-only hepatitis C treatments that are big improvements on earlier treatments that are less effective, require injections and cause flu-like side effects.
For decades, hepatitis C carriers had no options but older treatments centered on injections of interferon, a synthetic version of an immune system protein that caused many of the nasty side effects.
Much more effective treatments with easier side effects have come on the market in the past several years, including three others approved by the FDA since November last year.
Those are Johnson & Johnson’s Olysio and Gilead Sciences’ Sovaldi and Harvoni.
The latter two have drawn considerable criticism from patients and doctors for their exorbitant price — Sovaldi costs about US$1,000 per pill or US$84,000 for a course of treatment — though their maker points out that successful treatment is cheaper than a liver transplant.
AbbVie said the shortest approved course of therapy for Viekira, 12 weeks, is set to cost about US$83,320 at wholesale prices. Patients and insurers have been hoping the growing competition would start to reduce the prices.
Viekira Pak was tested in six patient studies involving 2,308 participants with chronic hepatitis C, some of them with cirrhosis.
The tests showed 91 percent to 100 percent of the participants receiving the new combination had no detectable levels of the virus in their blood 12 weeks after treatment ended, indicating they had been cured.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
TRANSFORMATION: Taiwan is now home to the largest Google hardware research and development center outside of the US, thanks to the nation’s economic policies President Tsai Ing-wen (蔡英文) yesterday attended an event marking the opening of Google’s second hardware research and development (R&D) office in Taiwan, which was held at New Taipei City’s Banciao District (板橋). This signals Taiwan’s transformation into the world’s largest Google hardware research and development center outside of the US, validating the nation’s economic policy in the past eight years, she said. The “five plus two” innovative industries policy, “six core strategic industries” initiative and infrastructure projects have grown the national industry and established resilient supply chains that withstood the COVID-19 pandemic, Tsai said. Taiwan has improved investment conditions of the domestic economy
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day